Winchester Medical Center

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease3 trials
• Atrial fibrillation1 trial
• Epilepsy1 trial
• Familial hypercholesterolaemia1 trial
• High blood pressure1 trial
• Peripheral artery disease1 trial
• Stroke1 trial
• Type 2 diabetes1 trial

Phase

• Phase 35 trials
• Phase 21 trial

Status

• Completed4 trials
• Active, not recruiting2 trials
• Recruiting1 trial
• Terminated1 trial
• Withdrawn1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Amgen1 trial
• Biosense Webster, Inc.1 trial
• Dr. Paul Lyons1 trial
• Mayo Clinic1 trial
• and 3 more

Running trials

• Recruiting

  A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

  NCT07227532· Biosense Webster, Inc.· Source

  Contact: Emily Purcell

• Active, not recruiting

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation1 recruiting

Closed trials

• Recruiting

  OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  NCT07136012· Phase 3· Amgen· Source

• Withdrawn

  Trial Investigating the Safety and Efficacy of BRC-003 in Refractory Post-Traumatic Epilepsy

  NCT06523725· Phase 2· Dr. Paul Lyons· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

  NCT04560998· Phase 3· Novo Nordisk A/S· Source

• Completed

  PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

  NCT03168776· Sino Medical Sciences Technology Inc.· Source

• Completed

  Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

  NCT02089217· Mayo Clinic· Source